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Abstract  
Recent advances in tissue engineering and regenerative medicine have shown that 
combining biomaterials, cells, and bioactive molecules are important to promote the 
regeneration of damaged tissues or as therapeutic systems.  Natural origin polymers have 
been used as matrices in such applications due to their biocompatibility and 
biodegradability. This chapter provides an up-to-date review on the most promising 
natural biopolymers, focused on polysaccharides and proteins, their properties and 
applications.  Membranes, micro/ nanoparticles, scaffolds, and hydrogels as biomimetic 
strategies for tissue engineering and processing are described, along with the use of 
bioactive molecules and growth factors to improve tissue regeneration potential. Finally, 
current biomedical applications are also presented. 
 
Keywords: Cell encapsulation; cryopreservation; composites; growth factors; hydrogels; 
hypothermal preservations; immunoisolation; membranes; micro/nanoparticles; natural 
polymers; proteins; regenerative medicine; scaffolds; tissue engineering.  
 
LIST OF ABBREVIATIONS 
 
ACE – Acemannan 
AF- Annulus fibrosus 
ALP- Alkaline phosphatase 
BC - Bacterial cellulose 
BMPs - Bone morphogenetic proteins 
CA - Carrageenan 
CaP- Calcium phosphates 
CAV- Chitosan/aloe vera 
CH/CS NPs - Chitosan-chondroitin sulfate nanoparticles 
CS - Chondroitin sulfate 
2D - Two-dimensional 
3D - Three-dimensional 
Da- Daltons 
DS- Dermatan sulfate  
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ECM - Extracellular matrix 
EGF- Epidermal growth factor 
ESCs -  Mouse embryonic stem cells  
FGF – Fibroblast growth factor  
GAGs- Glycosaminoglycans 
GelMA- Methacrylated gelatin 
GF- Growth factor 
GG- Gellan gum 
GG-MA- Methacrylated gellan gum 
hBMSCs- Human bone marrow mesenchymal stem cells 
hMSCs- Human mesenchymal stem cells 
HAp -Hydroxyapatite 
HA – Hyaluronic acid   
HS- Heparan sulfate 
HUVECs - Human umbilical vein endothelial cells  
IGF- Insulin growth factor 
IL- Ionic liquid 
IVD- Intervertebral disc 
MWCO - Molecular weight cut-off 
MSCs - Mesenchymal stem cells 
NP- Nucleus pulposus 
PDGF- Platelet-derived growth factor 
PDMS – Poly(dimethylsiloxane) 
PEG – Polyethylene glycol 
PL- Platelet lysate 
PLGA- Poly(lactic-co-glycolic acid) 
PRP- Platelet-rich-plasma 
PVP- Polyvinylpyrrolidone 
RP - rapid prototyping  
TE – Tissue Engineering 
TERM- Tissue engineering and regenerative medicine 
TGF- Transforming growth factor 
TMTD - Triazole–thiomorpholine dioxide 
SF- Silk fibroin  
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SiNP - Silica nanoparticles 
SRP- Stimulus-responsive polymers 
PNIPAAm - Poly(N-isopropylacrylamide)  
VEGF – Vascular endothelial growth factor  
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1. Introduction 
 
Tissue engineering and regenerative medicine (TERM) is a multidisciplinary field that 
combines three fundamental tools, namely biomaterials, adequate cells and signaling 
molecules aiming to replace and regenerate damaged tissues. Current efforts focus on 
developing strategies that include 3D-based matrices to support cells, promoting their 
differentiation and proliferation envisioning the formation of new tissues. Such 
approaches will provide the production of hybrid constructs with adequate structural and 
mechanical properties that behave as bioresorbable temporary implants to induce the 
tissue regeneration or replace failing or malfunctioning organs.  
Several materials have been proposed to be used in the processing of scaffolds, namely 
natural biodegradable polymers. Natural origin polymers derived from renewable 
resources, namely from algae, animal, plant, and microorganisms, offer the advantage of 
being similar to biological macromolecules, which biological environment is prepared to 
recognize and to deal metabolically with. Due to their similarity with the extracellular 
matrix (ECM), natural polymers may also avoid the stimulation of chronic inflammation 
or immunological reactions and toxicity, often detected with synthetic polymers. 
Therefore, the features of the natural polymers are the key players for designing 
therapeutic systems that can be used to deliver drugs or bioactive compounds efficiently 
to treat diseases or even to bioengineer functional tissues for organ replacement. This 
chapter provides an up-to-date review on the most promising natural origin polymers, 
namely polysaccharides (e.g. alginate, cellulose, chitosan) and proteins (e.g. collagen, silk 
fibroin, elastin) that  have been proposed to be used in tissue engineering (TE) strategies, 
with some emphasis on their properties, and the strategies used for the processing such 
kind of materials into membranes, scaffolds and hydrogels. Moreover, materials 
containing cells and/or bioactive cells or even cell encapsulation into these materials that 
can be used in a non-invasive way are also discussed.   
An overview of the properties, strategies and biomedical applications, namely cell 
encapsulation and intervertebral disc regeneration of natural polymers herein addressed 
is presented in Figure 1.  
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Figure 1: Overview of the properties, strategies and biomedical applications of natural 
polysaccharides and proteins for TERM.  
 
2. Polysaccharides and proteins  
2.1. Polysaccharides  
 
Polysaccharides consist of repeating monosaccharide units linked by glycosidic bonds. 
Besides, polysaccharides can be obtained or synthetized from different abundant 
renewable resources in nature, namely algae (e.g. alginate, agarose, carrageenan, 
fucoidan, and ulvan), plant (acemannan, cellulose, and starch), microbial (bacterial 
cellulose, dextran and gellan gum) and animals (e.g. chitin/chitosan, chondroitin sulphate, 
glycosaminoglycans, heparin and hyaluronan).1 As natural biopolymers polysaccharides 
are biodegradable, biocompatible and non-toxic.1b Furthermore, polysaccharides have a 
great number of reactive groups such as hydroxyl, carboxyl, and amino groups that make 
them easily chemically modified or physically blended.2 These characteristics together 
with their intrinsic and biological properties suggested that polysaccharides are promising 
biomaterials. The physicochemical and biological properties of the mentioned 
polysaccharides are reviewed in the following sections.  
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2.1.1. Algae polysaccharides  
 
Alginate is a linear polymer of (14)-linked D-mannuronic acid and (14)-linked L-
guluronic acid. 3 Alginate is present in the cell wall of brown algae as different salt forms 
of alginic acid, namely calcium, magnesium and sodium salts.3-4 Gelation is an important 
feature of alginates, and it depends on its molecular weight, molecular structure, and 
gelation agent concentration (e.g. calcium ions concentration).2c, 3 For instance, alginate 
gels can be formed through hydrogen bonding at low pH or by ionic interaction with di-
or polyvalent cations.2c, 5 Besides controllable gelation, alginate is recognized by its 
biocompatibility, immunogenicity, and low toxicity. In TE, alginate is used in the 
development of hydrogels, micro/nanoparticles, and beads, for various applications 
including wound healing, protein delivery, and cell encapsulation.3, 5 However, some 
drawbacks of alginate have been evidenced such as uncontrollable degradation profiles, 
inadequate mechanical properties and lack of cell recognition signals.2a Nevertheless, the 
application of conventional chemical modification on alginate including oxidation, graft 
copolymerization, sulfation, and esterification can enhance or tailor its properties, as 
reviewed previously.2a, 2b   
Agarose is a linear polysaccharide found in seaweeds composed of (13)-β-D-
galactopyranose-(14)-3,6-anhydro-β-L-galactopyranose unit. This neutral 
polysaccharide forms thermoreversible gels when solubilized in water.6 In biomedical 
applications, the thermosensitive character of agarose has been combined with other 
biomolecules as chitosan, gelatin, and fibrin.7 These approaches have been utilized in the 
formation of hydrogels that can be applied directly at the desired site; and in the 
fabrication of different bioengineered tissues, including skin and peripheral nerve.7b, 8  
Carrageenan (CAs) are highly sulfated linear polysaccharides, present in red algae, with 
alternating repeating 3,6-anhydro-D-galactose and β-D-galactose 4-sulfated units. The 
number of sulfate groups per disaccharide unit in the structure determines the type of CAs 
that can be kappa (κ), iota (ι) and lambda (λ) distinguished in the presence of one, two or 
three sulfate groups, respectively. One of its main properties relies on the ability to form 
thermoreversible gels at room temperature in the presence of appropriate counterions. 
Recently, κ –CA-based materials have gained wide interest for TE applications namely 
as an injectable matrix for the delivery of living cells, bone regeneration, designing drug 
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delivery systems due to their intrinsic thixotropic behavior, the versatility of processing 
and resemblance to GAGs.9 Moreover, the presence of functional groups (i.e. hydroxyl 
and sulphate groups) allows them to be easily modified, generating derivatives with 
improved properties and better stability.9a, 9c 
Fucoidan is an anionic sulfated polysaccharide extracted from marine brown algae. 
Structurally, fucoidan is composed of a backbone of (1→3)- and (1→4)-linked α-l-
fucopyranose residues; that may be organized in stretches of (1→3)-α-fucan or of 
alternating α(1→3)- and α(1→4)-bonded l-fucopyranose residues.10 Moreover, fucoidan 
is a water-soluble polymer with several biological properties for TE approaches including 
anti-inflammatory, anti-oxidative, anticoagulant, antithrombotic, anti-tumor and reducing 
blood glucose.11 In fact, the ability to combine fucoidan with other polymers like chitosan 
and gelatin and/or inorganic components, such as tricalcium phosphate and 
hydroxyapatite (HAp), has been explored for the production of matrices (e.g. 
micro/nanoparticles, fibers, and films) useful for oral delivery, burn wound healing and 
bone TE.  
Ulvan is a sulphated polysaccharide isolated from green algae belonging to Ulva sp.12 
The composition of ulvan is variable, but rhamnose, uronic acid, xylose and sulphate 
groups are the main components of this polymer.13 Recently, ulvan has been suggested as 
a starting material for designing many structures, namely nanofibers, membranes, 
hydrogels and 3D porous materials13-14. The applicability of these matrices may range 
from wound dressing to drug delivery and cell delivery. Moreover, ulvan can be easily 
modified through its functional groups (carboxyl, hydroxyl and sulphate groups) to 
achieve the needs for an envisaged biomedical application.  
 
2.1.2. Animal polysaccharides  
 
Chitin and chitosan are polysaccharides with great structural possibilities for the creation 
of the derivatives and matrices for different biomedical applications, including TERM.15 
Chitin (β-(1-4)-poly-N-acetyl-D-glucosamine) can be found in shells of crustaceous such 
as crabs and shrimps.15a Furthermore, chitin can also be extracted from endoskeletons of 
cephalopods. Depending on its source, chitin can be characterized by α- and β-form, 
distinguished by strong and weak inter- and intramolecular bonds, respectively.16 This 
polymer has appealing properties namely biocompatibility, tumor cell growth 
suppression, acceleration of wound healing and antimicrobial activity.1a, 15a These 
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properties have encouraged the production of chitin-containing products such as artificial 
blood vessels, tumor inhibitors, vascular implants and dressing for burns. Despite the 
promising biomedical use of chitin, its application has been limited due to its strong inter- 
and intra-molecular bonding between the polymer chain, which results in a lack of 
solubility in water and common organic solvents1a. Nevertheless, recent studies proposed 
that ionic liquids (ILs), defined as organic salts like 1-butyl-3-methylimidazolium 
acetate,17 can be used not only as a solvent but also as reaction media of some 
polysaccharides, including chitin,18 chitosan,19 cellulose20 and silk fibroin.21 In particular, 
chitin/IL solutions can be used in the preparation of 2D and 3D-based matrices namely 
gels, films, sponges and micro/nanoparticles. Given the performance of the resulting 
chitin-based matrices, they may be applied in drug delivery, bone regeneration, gene 
delivery, and skin repair.18a, 18c, 22 
Chitosan is the N-deacetylated derivative of chitin.15a Chitosan is recognized as an 
important biomaterial due to its intrinsic properties namely its polyelectrolyte and 
cationic nature, mucoadhesion, hemostatic action, film-forming ability, biodegradability 
and anti-microbial action.1a Moreover, chitosan is a versatile raw material for the 
designing of 2D and 3D-based matrices such as membranes, fibers, particles and 
composites at micro/nano level for applications in bone, skin and cartilage TE.15a The 
combination of chitosan with other polymers (natural or synthetic ones) and/or proteins 
are approaches frequently used to create blends and composites.23 Besides, chitosan 
derivatives have been developed using several chemical and physical procedures. These 
chitosan-based materials have suitable properties and functionalities for biomedical 
purposes, for instance, dermal substitutes, cancer diagnosis, drug delivery and gene 
therapy.15a With the rise of nanotechnology, chitosan, together with other 
macromolecules, has also been fabricated into various bionanocomposites, providing 
alternative applications in regenerative medicine and drug delivery vesicles.5, 24 
Glycosaminoglycans (GAGs) are linear, complex and polydisperse natural 
polysaccharides, composed of a repeating disaccharide unit formed by a hexose and a 
hexosamine. GAGs can regulate the action of proteins essential to bone and skin 
regeneration and modulate the biological performance of skin and bone precursor cells 
and their subsequent differentiation and gene expression. However, the precise action of 
GAGs varies according to their structural composition mainly on the degree of sulfation 
and polymer length. The sulfated GAGs such as chondroitin sulfate (CS), dermantan 
sulfate (DS), and heparan sulfate (HS) represent a group of bioactive polysaccharides 
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derived from animals. The characteristics of the mentioned GAGs together with their 
defined physical properties make them interesting material for TE. For instance, CS has 
functions in wound repair, response to infection, growth factor signaling, morphogenesis, 
and cell division, in addition to their conventional structural roles.25 Moreover, many 
studies using shark-derived CS suggests that this type of CS may reduce allergic response 
and have an anti-allergic effect. CS and DS chains have interesting functions in central 
nervous system development, wound repair, infection, growth factor signaling, and cell 
division.25 
Hyaluronic acid or hyaluronan (HA), is a water-soluble polysaccharide formed by a 
structure linear with a repeating disaccharide structure composed by α-1,4-D-glucuronic 
acid and β-1,3-N-acetyl glucosamine bonds. As a biomaterial, HA is suitable for a wide 
range of applications due to its biodegradability, biocompatibility, viscoelastic properties, 
nontoxicity, and nonimmunogenicity. Nonetheless, HA has low shape stability and poor 
mechanical properties. So, usually, HA is a key component in the preparation of 2D and 
3D matrices such as membranes, hydrogels, and scaffolds that can be either chemically 
or physically modified or degraded controllably.26 Hence, HA and HA-based materials 
serve as excellent tools for many biomedical needs such as orthopaedic, cardiovascular, 
pharmacologic and oncologic applications.26-27 
 
2.1.3. Plant polysaccharides  
 
Acemannan (ACE) is a -(14)-acetylated polymannose present in the inner leaf gel of 
Aloe vera plant, a medicinal plant.28 ACE has been described by its multifunctional 
properties such as immunomodulatory activity, antiviral, antioxidant and antibacterial 
actions.28-29 Therefore, ACE acts as a bioactive molecule, exerting an immunostimulatory 
effect by activating macrophages,30 induction of VEGF expression and wound healing 
actions.29, 31 Recent studies demonstrated that ACE stimulated gingival fibroblast 
proliferation 32, dental pulp fibroblast proliferation,33 periodontal tissue regeneration 34 
and bone marrow stromal cell proliferation and differentiation in vitro.31 These works 
suggested ACE as a therapeutical agent for tissue repair. However, further research 
studies are needed to validate and explain the action mechanism of ACE in healing. 
Cellulose, the most abundant polysaccharide in nature, is constituted by β(14) linked-
D-glucopyranose units. The polymeric chains are packed through hydrogen bonds and 
van der Waals forces forming fibrous structures called microfibrils. These nano structured 
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microfibrils with high structural strength and stiffness. This crystalline part is named 
nanowhiskers. Despite its great availability, cellulose has a high crystallinity degree and 
rigid intra/intermolecular hydrogen bonds which result in its insolubility in most solvents. 
To overcome these drawbacks, many chemical functionalizations based on hydroxyl 
groups, as e.g. esterification, graft copolymerization, and selective oxidation has been 
used to generate different cellulose derivatives.2a For instance, oxidized cellulose is used 
as an excellent hemostatic material in various surgical procedures; while other cellulose 
derivatives (in hydrogel and aerogel form) have been used in wound healing, 3D-cell 
culture, and drug delivery systems.35 Besides, recent advances on the homogeneous 
modification and functionalization of cellulose have also been achieved using ILs, 
opening novel possibilities for its biomedical applications.20 For example, Park et al. 
produced cellulose/chitosan composite nanofibers using 1-ethyl-3-methylmidazoliium 
acetate, which could be used as an antibacterial reagent to treat skin ulcers.36 On a 
composite perspective, the use of cellulose crystals (e.g. nanowhiskers) is based on their 
high stiffness, being relevant as a reinforcement strategy in several systems such as 
hydrogels systems. 27b, 35 
 Starch is a biopolymer composed of two major components, namely -amylose and 
amylopectin. Starch can be found in many plant sources, such as corn, rice, potato, and 
wheat.37 Depending on the source, the physico-chemical and functional properties of 
starch can vary. Chemical and physical modifications, and/or even combinations with 
other natural or synthetic polymers are some of the approaches applied onto starch to 
overcome its lack of processability. In TE, the starch-based materials e.g. 3D scaffolds, 
micro/nanoparticles, bone cement, and hydrogels, have been used as a carrier for 
controlled release of drugs.  
 
2.1.4. Microbial polysaccharides  
 
Bacterial cellulose (BC) can be produced by Gluconacetobacter xylinus or Acetobacter 
xylinum.38 Although its similar molecular formula to plant origin cellulose, BC is 
characterized by a crystalline nano-fibrillar structure which creates a large surface area 
that can retain a large amount of liquid.38a, 38c BC has also been proposed to be used as an 
effective wound material due to its unique properties such as versatility, moldability in 
situ, biocompatibility, high water-holding ability, cost effect production and high 
mechanical strength in the wet state.38b, 38c, 39 Furthermore, BC is used as wound dressing 
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composites with collagen type I,40 chitosan 23a, 41 and aloe vera.42 BC could be used in the 
production of scaffolds, transdermal applications and as a pharmaceutical excipient in 
drug delivery systems.35, 43 In transdermal drug delivery, for instance, BC membranes 
could work bilaterally, both to deliver drug and absorb exudates.  
Dextran is a biodegradable neutral bacterial exopolysaccharide consisting of repeating 
glucose subunits. Dextran is soluble in water and organic solvents, and this feature can 
be used in the preparation of different structures through blending dextran with bioactive 
agents or hydrophobic polymers. For instance, the interest in dextran hydrogels for soft 
TE has increased due to their great biocompatibility, the capability to reduce nonspecific 
protein adsorption and cell attachment. However, these properties are not sufficient for 
dextran hydrogels to fulfill their role to act as a TE scaffold. The conjugation of bioactive 
moieties such as RGD on dextran could facilitate tissue growth and regeneration.44 
Moreover, dextran can also be chemically modified to form spherical, tubular and 3D 
network structures.45 Dextran has also been applied in nanomedicine. Dextran 
nanoparticles have superior aqueous solubility, high cargo capacity and intrinsic 
viscosity, and short storage period.46 Therefore, the features of dextran made it suitable 
as nanodrug carrier, cell imaging system, and nanobiosensor.  
Gellan gum (GG) is an anionic extracellular polysaccharide, composed by 
approximately, 60% glucose, 20% glucuronic acid, and 20% rhamnose as a repeating unit, 
and two acyl groups, acetate and glycerate bound to glucose residue adjacent to 
glucuronic. GG is recognized as a thermally reversible gel with excellent stability and 
high gel strength. However, in its high acyl form, GG produces transparent, soft, elastic 
and flexible gels, whereas the low acyl form results in brittle gels. These features have 
stimulated different approaches to use it as injectable hydrogels to regenerate and repair 
the damaged cartilage,47  and chemically modified for invertebral disc (IVD) regeneration 
48.  
 
2.2. Proteins 
 
Proteins are one of the versatile groups of macromolecules in living systems and play 
important functions in almost all biological processes. Proteins have also been used for 
the development of innovative materials for biomedical purposes mainly due to their (i) 
availability on a large scale and low cost; (ii) biodegradability since their degradation 
products are composed of amino acids that can be resorbed as nutrients; (iii) chemical 
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reactivity; and (iv) excellent biocompatibility. Given their unique properties, efforts have 
been expended in developing protein-based materials including films, capsules, foams, 
scaffolds, composites, and gels, through their association or not with bioactive 
compounds. These matrices have gained prominence as drug delivery systems, 
biosensors, and scaffolds for tissue regeneration. Moreover, the design approaches such 
as genetic engineering can be used for the synthesis of protein-engineered biomaterials, 
tailoring their properties (e.g. cell adhesion, elasticity, and biodegradability), and 
reducing the problems associated with those obtained from natural sources.  
The features of the most promising proteins, namely collagen, gelatin, elastin, silk fibroin, 
sericin and soy protein used for TERM are described in the following paragraphs.   
 
Collagen and gelatin 
 
Collagen is the most abundant protein present in mammalian tissues (cornea, blood 
vessels, skin, cartilage, bone, tendon, and ligament) and is also the main component of 
the ECM. Gelatin is the partially hydrolysed form of collagen. Although sources of 
collagen and gelatin are bovine and porcine skin, recent studies have been shown their 
extraction from marine sources (e.g. marine sponges, fish skin) using simple protocols.16 
Both collagen and gelatin are the most preferred ECM proteins used in TE. They can be 
processed into fibers, films, and foams to engineer many tissues such as bone, cartilage, 
ligament, nerve and heart.49 Depending on the biomedical purpose, improvement of the 
physical, chemical and biological properties of collagen can be achieved through its 
combination with other polymers. Similar to collagen, the use of gelatin in TE has been 
correlated with its appealing features such as cell-adhesive structure, low cost, and 
biocompatibility. Gelatin can be processed as composite scaffolds, nanoparticles, 
employed as a size-controllable porogen, and acted as surface coating agent.50 Recent 
research has shown the proficiency of methacrylated gelatin (GelMA) for bioprinting and 
micro-structured patterned applications. The derived structures are suitable for bone, 
cartilage, cardiac, vascular tissues, drug, and gene delivery.51 
Elastin is a vital protein component of the ECM present in many mammalian tissues, 
which require elasticity as part of their function,52 including vasculature, skin and lungs. 
Mature elastin is an insoluble polymer composed of several tropoelastin molecules 
covalently bound to each other by cross-links. The nature of elastin itself has hindered 
the study of its properties and structure, mainly due to its insolubility in water and 
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backbone mobility. Elastin has inherent signaling properties that promote diverse 
responses, including chemotaxis, cell growth, and tissue homeostasis. Using the benefits 
effects of these characteristics, elastin and derivatives (tropoelastin and elastin derived 
peptides) can be used in the production of elastin-based materials and as surface coatings 
for polymers in order to improve cell adhesion and function on tissue engineered 
products. Elastin-like macromolecules are genetically engineered materials rooted in the 
repeating sequence of natural elastin.53 They can be synthetized with a high degree of 
specificity and control, which is feasible by chemical methods. In fact, recombinant 
elastin-like polypeptides (ELPs) can be assembled into 3D matrices with tailored 
mechanical and thermal properties as well as unique functionalization opportunities using 
both enzymatic and genetic ways. Besides, incorporation of non-natural elements and 
inorganic materials in elastin-based materials could extend their application range, 
namely in diagnostic imaging and target therapeutic delivery.54 
Silk are a class of proteins containing fibroin (70– 80%), the structural protein of silk 
fibers, and sericin (20–30%), the water-soluble glue-like protein that encased ﬁbroin 
fibers. Silk fibroin (SF) is composed by glycine, alanine, and serine in different 
percentages. SF fibers are obtained from diverse sources such as non- and mulberry 
silkworm Bombyx mori, insects, and spiders.55 SF possess good biocompatibility, 
elasticity, toughness, suitable mechanical properties and biodegradability with 
controllable degradation rates, make it a good biomaterial for TERM. SF is rich in β -
sheet structures owing to hydrophobic domains thus influence its mechanical properties, 
biodegradation rate and the ability to support the cell adhesion and differentiation of 
MSCs Extensive studies have been carried out on the processing, blending and/or 
chemical modification of SF. It has also been combined with biomacromolecules as e.g. 
chitosan to form membranes, scaffolds, composites, micro/nanoparticles, nanofibers and 
hydrogels and/or with inorganic components like calcium phosphate (CaP) and HAp to 
generate composites.56 These approaches have shown the benefits effects of SF-based 
structures for skin cartilage, bone, and ligament TE. 
Sericin comprises a variable amino acid compositions such as serine, glycine, glutamic 
acid, aspartic acid, threonine, and tyrosine. This protein is considered a waste during silk 
processing. However, sericin exhibits attractive bioactive properties such as antioxidant, 
moisturizing ability, pH responsiveness and mitogenic effect on mammalian cells,57 with 
potential applications in regenerative medicine. Sericin-based biomaterials such as 
sponges, hydrogels, micro/nanoparticles, composites, and films produced by ethanol 
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precipitation, crosslinking or blending with other polymers and/or with inorganic 
components 58 have been employed as dermal reconstruction and wound dressing for skin 
tissue repair, bone TE, and drug delivery.59 
Soy protein is a globular protein isolated from soybeans. About 90-95% of the soy is a 
storage protein, with two subunits, namely 35% conglycinin (7S) and 52% glycinin (11S). 
Soy protein has advantages over the various types of natural proteins employed for 
biomedical applications, namely its low price, non-animal origin and relatively long 
storage time, and stability. Besides, the combination of its properties with a similarity to 
tissue constituents and a reduced susceptibility to thermal degradation makes soy protein 
a plant-derived macromolecule of interest in the biomedical field.60 Membranes, fibers, 
microparticles and thermoplastics-based soy materials have been developed associating 
soy protein with other proteins (e.g.  wheat gluten,61 casein 62), polysaccharides, such as 
cellulose,63 chitosan,64 and synthetic materials. The resulting matrices are helpful for 
tissue regeneration,65 drug delivery system, and wound dressings.1a, 64b 
 
2.3. Bioactive agents and growth factors 
One of the significant challenges in TERM involves the production of matrices associated 
with bioactive signaling molecules that can promote cell adhesion, proliferation, 
differentiation, and metabolic activity for the in vivo regeneration process. These 
molecules are grouped in mitogens (that stimulate cell division), growth factors (with 
proliferation-inducing effects), and morphogens (that control generation of tissue form). 
In particular, growth factors (GFs) are signaling molecules capable of instructing cells, 
stimulating cellular growth, proliferation, healing and cellular differentiation in a 
biological environment. Given the critical role of GFs stability in cellular responses, of 
in vivo situations, natural polymers- based systems are good platforms as bioactive 
delivery substrates. These matrices could affect not only the encapsulation efficiency of 
the bioactive agents but also cell fate. Distinct strategies have been employed to prolong 
their release rate and increase their therapeutical effect in TE, namely (i) chemical 
immobilization of GFs into the polysaccharide- or protein-based matrices, and (ii) 
physical encapsulation of GFs in the delivery systems.66 Examples of GFs and their 
carrier-based polymeric systems used in TE are presented in Table 1. 
Platelet lysate (PL) has been increasingly explored in TERM as a natural and cost-
effective resource of GFs and multiple proteins, and/or as a support for cell growth and 
differentiation. In fact, platelets have a wide range of cytokines such as the isoforms of 
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Insulin Growth Factor (IGF), Platelet-Derived Growth Factor (PDGF), Transforming 
Growth Factor (TGF), among others. Recent strategies for a controlled incorporation of 
PL have been developing using nanocoatings by layer-by-layer with marine origin 
polymers 67 (see Figure 2), and the production of biomimetic 3D hydrogel structure based 
on the assembly of chitosan-chondroitin sulfate nanoparticles (CH/CS NPs) carrying 
PLs.67 
 
 
 
 
Figure 2. Main steps for the preparation of PL/Polysaccharides Layer-by-Layer 
assembled nanocoatings. a) Platelet isolation from human blood as Platelet-Rich-Plasma 
(PRP) and examples of bioactive proteins than can be found in the enriched protein 
cocktail; b) PL preparation: PRP activation by platelet disruption induced by thermal 
cycles for the release of the inner content and (c) Layer-by-Layer deposition combining 
PL with several PEs which respective functional groups and content are indicated. 
Adapted from Ref 67 with permission.    
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Table 1: Growth factors, their main functions and some examples of polymer-based 
carrier systems used in TE. 
 
Growth factors Main functions Examples of 
polymer-based 
carrier systems 
Ref 
BMPs Osteoblast cells differentiation and 
migration 
To induce MSCs to differentiate into 
bone. 
Heparin-
conjugated fibrin 
system 
68 
EGF Regulation of epithelial cell growth, 
proliferation and differentiation 
PLGA/gelatin 
hybrid 
nanofibrous 
scaffolds 
 
69 
FGF Migration, proliferation and survival 
of endothelial cells 
Gelatin sponge, 
Chitosan/fucoidan 
nanoparticles 
24b, 70 
IGF Cell proliferation, inhibition of cell 
apoptosis 
 
Collagen/GAG 
scaffold 
71 
NGF Survival and proliferation of neural 
cells 
Chitosan-β-
glycerophosphate 
hydrogel 
72 
PDFG Embryonic development, 
proliferation, migration, growth of 
endothelial cells 
 
Gelatin hydrogels 73 
TGF Wound healing and increase cell 
proliferation and 
differentiation 
Chitosan 
microspheres 
74 
VEGF -Migration, proliferation and 
survival of endothelial cells. 
-Induce angiogenesis 
 Star-
poly(ethylene 
glycol)-heparin 
hydrogel 
75 
 
Abbreviations: BMPs: Bone morphogenetic protein; EGF: Epidermal growth factor; 
PLGA: Poly(lactic-co-glycolic acid); FGF: Fibroblast growth factor; IGF: Insulin-like 
growth factor; NGF: Nerve growth factor; PDFG: Platelet-derived growth factor; TGF: 
Transforming growth factor; VEGF: Vascular endothelial growth factor.  
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3. Strategies for tissue engineering  
Diverse strategies have been developed to engineer new tissues mimicking the natural 
tissue ECM to enhance cell-biomaterial interactions, and promote cell adhesion, 
proliferation, and differentiation ability. These strategies hold micro/nanoparticles, 
membranes, scaffolds, and hydrogels, with a specific design, controlled degradation rate, 
mechanical properties, and porosity for efficient gases, nutrients, and regulatory factors 
transport. 
Conventional techniques such as foam replica method, solvent casting and particulate-
leaching, freeze drying, gas foaming, and phase separation, are inexpensive and flexible 
to optimize physicochemical properties and have been used to produce structures. Rapid 
prototyping, supercritical fluid technology bioprinting, photolithography, microfluidics 
and electrospinning, as more sophisticated techniques, are also used for 3D structures and 
fibers, respectively, allowing the possibility of incorporating pharmaceutical agents. A 
brief description of such strategies is provided below. 
 
Membranes  
 
Membranes have been used in different TE applications, namely in wound healing, 
construction of drug delivery systems and diagnostic devices, due to its ease of 
manufacturing and self-application.1a, 76 Membranes can be produced using solvent 
casting with or without porogen, freeze-drying technique, spin casting, and 
electrospinning.77 Solvent casting are the technique commonly used in the preparation of 
polymeric membranes, owing the advantage of producing large and constant surface 
areas. This method consists in the polymer dissolution in an appropriate solvent and 
subsequent solvent evaporation. Additionally, drugs or specific molecules can be 
incorporated during the dissolution of the polymer or even on the casted film. The 
membrane structure and its properties are influenced by many experimental factors such 
as choice of solvent and non-solvent, polymeric solution composition, and humidity. 
Furthermore, instead of using pure polymer, two or more polymers can be mixed to form 
blends which are useful in the production of membranes with desirable properties. Many 
polymeric membranes have been produced using polysaccharides, proteins or their 
combinations envisioning biomedical TE applications. For example, Silva et al. 
developed blended membranes composed by chitosan and aloe vera (CAV) using the 
solvent casting technique.15b Results showed that the incorporation of AV into chitosan 
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provided blended membranes with better physical (roughness, degradation rate, 
wettability, mechanical properties) and cellular response (Figure 3) when compared to 
chitosan alone.  
 
 
 
Figure 3: Calcein-AM staining of human dermal fibroblasts cells cultured for 1 and 3 
days on the membranes (chitosan and chitosan/aloe vera, CAV). Adapted from Ref 15b 
with permission.    
 
The membranes surface properties, as e.g. roughness, wettability and surface energy, are 
important parameters that influence their biomedical application. Therefore, modification 
of the membrane surface is often needed to enhance the interaction of such material with 
the host or biological fluid and suppress the immune response. Various methods have 
been employed for modifying polymer surfaces including chemical modification, UV, 
gamma irradiation, and plasma surface modification. These modifications can determine 
the possible interactions of polymers with bioactive agents (e.g. growth factors, drugs). 
In plasma surface modification, the material is exposed to a partially ionized gas resulting 
in the formation radicals on the polymer surface that will modify the surface.1a, 78 Also, 
the activation of the membrane surface can be used to create smart surfaces, where the 
wettability can be responsive to the change of external variables.79 For example, surface 
properties of membranes can be modulated in response to an external stimulus (e.g. pH 
or temperature), and this characteristic could be useful to modulate the release of drugs. 
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A similar effect can be achieved through grafting of the monomer by chemical initiators 
using free radical polymerization methods. In that case, surface bound stimulus 
responsive polymers (SRP) can also be incorporated into membranes to create 
thermosensitive membranes.  
 
3.1. Micro- and nanoparticles  
Micro- and nanoparticles can be used in a large variety of TERM applications ranging 
from therapeutic delivery,80 cardiovascular imaging,81 to in vitro diagnosis,82 
incorporations in scaffolds or hydrogels,83 or incorporated in biomaterials for the delivery 
of bioactive factors.83a  
Micro- and nanoparticles have properties that can make them more or less useful for 
different applications, with particle diameters usually ranging from 1 to 100 µm, and 1 to 
100 nm, respectively. The nanoscale dimension has unique physicochemical properties, 
such as ultra-small size, large surface area, and high reactivity when compared to the 
conventional microsized particles.84 Nanoparticles are functionalized or surface-modified 
by capping certain functional groups on their surfaces, with specific recognition chemical 
moieties and enhanced efficacy, while simultaneously reducing side effects, due to 
properties such as targeted localization in tumors and active cellular uptake.85 Various 
morphologies have been used to prepare nanoparticles, including liposomes, nanospheres, 
nanocapsules, micelles, and dendrimers,80a, 86 which main characteristics are well 
documented in the literature.87  
Numerous micro- and nanoparticle compositions have been used in tissue engineering, 
including natural and synthetic polymers,23b, 88 inorganic/ceramic,89 magnetic,90 and gold 
nanoparticles.91 For example, chitosan nanoparticles loaded with dexamethasone 
presented a significant improvement of osteogenic differentiation of hMSCs for bone 
tissue regeneration.92 Park et al.93 produced a hybrid composite scaffold using 
nanofibrous 2,2,6,6-tetramethylpiperidine-1-oxyl (TEMPO)-oxidized bacterial cellulose 
and HAp with enhanced cell adhesion, migration, growth, mineralization, and 
differentiation for bone tissue regeneration. In a different study, mesoporous silica-based 
nanoparticles incorporating bone-forming peptide derived from BMPs-7 were developed 
to obtain a system for osteogenic factor delivery.94 Results showed high cell proliferation 
and alkaline phosphatase (ALP) activity, making it a potential candidate for bone 
regeneration and bioimplant coating applications. A study by Chen et al..95 demonstrated 
that the presence of biphasic tricalcium phosphate microparticles incorporated into a 
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hyaluronic acid-g-chitosan-g-poly-N-isopropyl acrylamide hydrogel presented better cell 
proliferation and osteogenic differentiation than in the hydrogel alone.  
Several methodologies have been presented in the literature for fabrication of polymeric 
micro/nanoparticles such as emulsification/solvent evaporation,96 nanoprecipitation (also 
known as solvent displacement method),97 salting out method,98 ionic gelation,24a spray 
drying,23b sol-gel,99 supercritical fluid technology,100 microfluidics,101 and 
electrospraying.102 Manufacturing process should ideally allow the production of large 
quantities of particles with a narrow size distribution, with control of particle size, 
porosity and surface characteristics. Among them, the emulsion method is the most 
popular technique, which consists in the dispersion or dissolution of molecules into a 
polymer solution and emulsified to form micro/nano droplets that are further dried after 
solvent removal. However, the use of organic solvents is a disadvantage since it can lead 
to denaturation of protein-based drugs, thus increasing the variability in drug loading, 
encapsulation efficiency, size and surface morphology of nonhomogeneous particles.103 
To overcome these limitations, electrospraying technique has the potential to generate 
narrow size distributions of submicrometric particles, with limited agglomeration and 
high yields.104 An example is presented in a study by Wang et al.96 where it was fabricated 
a multiple-drug delivery system consisted of chitosan nanoparticles and 
polyvinylpyrrolidone (PVP) micro/nanocoating with core–shell structures, using ionic 
gelation and emulsion electrospray methods (Fig. 3). Results showed a successfully 
encapsulated dual model drugs, naproxen, and Rh.B, in the shell and core regions, with 
good release controllability. 
Another processing method, often used by our group, for the fabrication of polymeric 
spheres, is based on the drop of the liquid precursor containing the polymer over 
superhydrophobic surfaces.105 This method presents advantages over conventional 
emulsion and gelation techniques as the contact of the dispensed drops with an outer 
liquid environment is avoided. In addition, this process allows the encapsulation of living 
cells and/or therapeutic molecules for tissue engineering applications.106  
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Figure 4: (A) An optical micrograph of the micro/nanoparticles, and (B) scanning 
electron micrograph of (naproxen/chitosan)/(Rh.B/PVP) core/shell micro/nanoparticles 
with naproxen/chitosan as the core and Rh.B/PVP as the shell. Adapted from Ref. 96 with 
permission.  
 
3.3. Scaffolds 
 
Scaffolds are defined as porous 3D support structures of the surrounding tissues 
mimicking ECM, with basic requirements, namely: (i) to promote cell-biomaterial 
interactions, cell adhesion, growth, and migration; (ii) to facilitate transport of mass, 
nutrients, and regulatory factors to allow cell survival, proliferation, and differentiation; 
(iii) controlled degradation that approximates the rate of tissue regeneration under the 
culture conditions of interest; (iv) possess adequate mechanical properties necessary to 
temporarily offer structural support until the formation of new tissue occurs, like tensile 
strength and elasticity; and (v) to elicit a minimal degree of inflammation or toxicity in 
vivo.107 Moreover, instead of simple injection of cells to the defects, scaffolds have de 
advantage of allowing cell transfer into a defect site and to restrict cell loss.108 
Scaffolds targeted for TE and regeneration have been developed using various natural 
and synthetic polymers, and bioactive inorganic materials, with specific pore size, 
porosity, surface-area-to-volume ratio, and crystallinity.109 Composite materials 
combining a polymeric matrix and inorganic materials, as fillers, resulting in a single 
structure with significantly improved mechanical and biological properties, also appeared 
as a strategy for tissue engineering.110 Special interest has been attributed to 
nanocomposites for bone tissue engineering and regeneration due to the nanosized 
features of the fillers which can intensely improve the tissue bonding capacity of the 
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polymeric matrices, that the individual materials cannot attain thus allowing the 
production of better biomaterials.111 
Different technologies applied for scaffolds fabrication embrace foam replica method,112 
salt-leaching,113 freeze-drying,109, 114 phase separation,115 gas foaming,116 supercritical 
fluid,117 rapid prototyping,22 and electrospinning.118 Barbani et al.119 produced a 
gelatin/HAp nanocomposite scaffold with an elastic modulus similar to that of natural 
bone, using the freeze-drying technique. It was shown that HAp scaffolds supported the 
adhesion and proliferation of hMSCs onto the scaffolds. Recently, Martínez-Vázquez et 
al.120 fabricated a 3D porous scaffold for bone regeneration and drug release capability, 
consisting of gelatine and Si-doped HAp through rapid prototyping technique, with 
adequate macroporosity for vascularization and microporosity that enables fluid 
exchange, as well possessing mechanical properties close to those of trabecular bone. 
Our group has been developing mono- and bilayered porous structures for osteochondral 
tissue engineering applications. Yan et al.109 developed a nanocomposite scaffold of SF 
and CaP using salt-leaching and freeze-drying methods, with superior mechanical 
properties and controllable porosity. The scaffolds supported new bone ingrowth, and no 
acute inflammatory was observed after 3 weeks of implantation. Based on their previous 
studies, the same authors fabricated bilayered scaffolds composed of an SF layer and an 
SF/nanoCaP layer, with different features (e.g. mechanical, chemical or morphology 
properties) for the simultaneous regeneration of the cartilage and the subchondral bone 
(Fig. 5).121 It was shown that the scaffolds integrated well with the host tissues and 
allowed tissue ingrowth when implanted in rabbit knee critical osteochondral defects. 
Furthermore, the bilayered scaffolds supported cartilage regeneration in the top silk layer 
and encouraged large amounts of subchondral bone ingrowth and angiogenesis in the 
bottom silk/nanoCaP layer.  
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Figure 5: The interface of the bilayered scaffolds showing the different regions from the 
silk layer to the silk-nanoCaP layer: (a) Macroscopic image (scale bar: 3 mm), and (b) 
SEM image (scale bar: 500 μm). Adapted from Ref121 with permission.  
 
3.4 Hydrogel materials 
Hydrogel-based materials, often classified as natural or synthetic polymers networks, are 
pre-formed by chemical or physical crosslinking of water-soluble precursors.122 This 
class of biomaterials is an attractive candidate for building 3D structures that resemble 
the physical characteristics of the ECM because of their high water content, viscoelastic 
nature, and the easy diffusion of bio-macromolecules.122-123 Hydrogels are polymer 
networks extensively swollen with water held together by (i) primary covalent crosslinks; 
(ii) hydrogen bonds; (iii) ionic forces; (iv) affinity or “biorecognition” interactions; (v) 
physical entanglements of individual polymer chains; (vi) polymer crystallites; (vii) 
hydrophobic interactions; or (viii) a combination of two or more of the previous 
interactions.124 Among them, naturally derived polymers recently used in hydrogel 
structures include collagen type I,125 alginate,126 HA,27b, 127 chitosan,7a, 125b, 128 gelatin,126b, 
128-129 GG,130 agarose,7a SF131 and fibrin.27c, 132 Hydrogels have recently emerged as a 
promising platform for 3D cell encapsulation and culture.123a Thus, their biomedical 
application depends to a large extent on their bulk structure. By controlling the chemical 
composition and crosslinking density, network structure, and pore size can be tuned and 
customized for a given application in TE.123c There are several forms to categorize 
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hydrogels, based on the preparation method, ionic charge or physicochemical structural 
features. Some of the most used fabrication techniques reported in the last years are 
highlighted in this section. 
(1) Injectable hydrogels 133  have the potential to be minimally invasive delivered. Most 
of the hydrogels are injectable, and they can be formed via photopolymerization,129, 134 
which can be carried out under mild conditions in the presence of living cells. This allows 
homogeneous seeding of cells throughout the scaffold materials and formation of 
hydrogels in situ.122 Alternative polymerization methods include the thermal 
polymerization,133a, 135 by using alginate modified with glycidyl methacrylate and calcium 
as cross-linker to produce a thermal polymerizable alginate at physiological conditions. 
Human umbilical vein endothelial cells (HUVECs) were encapsulated in the modified 
hydrogels in situ at 37 ºC, revealing that cell viability and proliferation were unaffected 
by macromonomer concentrations, suggesting the potential application in the field of 
TE.135 However, the lower mechanical properties of the developed hydrogels restrict the 
potential range of some TE applications. Hybrid injectable hydrogels show to be more 
complex systems that combine well-evolved biological mechanisms, such as high affinity 
and specificity of binding, with tailorable hydrogel properties (e.g., mechanical stability 
and environmental-responsive properties).122 Research groups report the development of 
bioactive organic-inorganic hybrid materials as injectable hydrogel collagen, collagen-
chitosan systems for bone tissue regeneration with silica nanoparticles (SiNP) prepared 
in situ.133b The in vitro studies on fibroblast cell viability indicated that the SiNP dispersed 
in the biopolymer matrix had a positive effect on cell viability. Recently, other study 
reports biohybrid temperature-responsive poly(N-isopropylacrylamide) PNIPAAm-
Gelatin-based injectable hydrogel with good bioactivity as well as appropriated 
mechanical properties for cardiac TE.136. 
 
(2) Bioprinting comprises a group of biofabrication technologies for 3D constructs by 
precisely printing biocompatible materials, cells and biochemicals in predesigned spatial 
positions.137 During the last years, a more interesting view is the printing and patterning 
in 3D of all the components that make up a tissue (cells and matrix materials) as a bioink 
to generate structures analogous to tissue. It can be found different printing approaches 
based on inject-based and extrusion-based systems that use a nozzle for the deposition of 
the hydrogel material.137-138  
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This implies that rheological properties, such as viscosity, shear forces and the 
mechanism by which the hydrogel is cross-linked to form a stable matrix, plays an 
important role allowing the ability of the hydrogel to be handled, deposit, stacked and 
retain volume over the time. Nevertheless, laser-based printers such as stereolithography, 
are nozzle-free systems that require different properties for the transfer of a hydrogel 
material from the laser absorbing donor slide to the recipient slide.137, 139 These 
technologies have been successfully applied to fabricate biodegradable 3D constructs 
with complex architectures and heterogeneous composition. As shown in Figure 6, the 
use of bioprinting strongly depends on the development of novel biomaterials exhibiting 
fast crosslinking schemes and appropriate printability, cell-compatibility, degradability 
and biomechanical properties.137, 140 
 
Figure 6: Concept map of the variables and relations to be considered when assessing a 
hydrogel for bioprinting applications. Reprinted from Ref 137 with permission.  
 
Thus, photocrosslinkable hydrogels showed to be attractive materials for bioprinting 
since they provide fast polymerization under cell-compatible conditions and excellent 
spatiotemporal control over the gelation process.139a Since bioprinting uses a layer-by-
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layer additive manufacturing approach is of high relevance that the hydrogel presents 
high viscosity and a fast cross-linking for the fabrication of 3D structures. 
Also, after cells been deposit, the hydrogel composition may play an important role in 
supporting cell viability and proliferation. Figure 7, summarizes the typical process for 
bioprinting 3D tissues. Very few materials are available that fulfill requirements for 
bioprinting as well as provide adequate properties for cell encapsulation during and after 
the printing process. Typical natural materials previously referred in this section included 
in the hydrogels formulations are alginate and gelatin precursors.139a, 141 In a recent study, 
these precursors were tuned with different concentrations of HAp. In vitro studies 
revealed that hMSCs mixed into the hydrogel precursor survived the printing process and 
showed high cell viability.141 By adding factors other than HAp, these hydrogels could 
be used as a bioink for applications in microsphere deposition, drug release and TE 
applications. 
 
 
Figure 7: Typical process for bioprinting 3D tissues. Imaging of the damaged tissue and 
its environment can be used to guide the design of bioprinted tissues. Biomimicry, tissue 
self-assembly, and mini-tissue building blocks are design approaches used singly and in 
combination. The choice of materials and cell source is essential and specific to the tissue 
form and function. Common materials included synthetic or natural polymers and 
decellularized ECM. Cell sources may be allogeneic or autologous. These components 
have to integrate with bioprinting systems such as inkjet, microextrusion or laser-assisted 
printers. Some tissues may require a period of maturation in a bioreactor before 
transplantation. Alternatively, the 3D tissue may be used for in vitro applications. 
Reprinted from Ref 142with permission. 
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(3) Photolithography and soft lithography techniques are used for cell encapsulation.143 
Both methods have also been developed by using a variety of other polymeric 
biomaterials such as polyethylene glycol (PEG), and alginate hydrogels.144 
Photolithography involves UV light through a photomask on to a substrate coated with a 
photoresist while; soft lithography includes a range of methods mostly in the field of 
microfluidics that is used to prepare microstructured elements from a polymeric 
material.145 Soft lithography techniques include microfluidic patterning, stencil-assisted 
patterning, and micro-contact printing. Photolithography can provide a broad range of 
features, varying from micrometers to sub-microns (e.g.100 nanometres). 
Photolithography technique uses light or photons to transfer the geometric shapes of a 
mask to a light-sensitive surface. This fabrication enables to polymerize and cross-link 
polymers, resulting in a 3D scaffold. Advantages of this technique are the uniform cell 
encapsulation, the good special and temporal control of reaction kinetics, easy control of 
pore size by varying the selected polymer and its concentration. The main disadvantage 
is the use of multiple photomasks for multilayered scaffolds and the use of photo-cross-
linkable polymers in the photolithography techniques. In addition, some challenges need 
to be solved such as the lack of resolution, economic viability and unsuitability of UV-
sensitive biological materials for pattering.146 Recent advances show the capability for 
producing environmentally triggered, self-folding, non-fouling and permeable hydrogel 
scaffolds, combined with nano- and micropatterned on both surfaces in a one-step 
photolithographic system.143a This was possible by combining serial hot embossing of 
sacrificial layers and photolithography. For each pattern, a mastering process was 
required in which quartz, silicon or PDMS stamps can be prepared, to be used in 
subsequent hot embossing and photolithography steps. The obtained patterned hydrogel 
films can be triggered consecutively allowing for successive rolling and unrolling 
depending on the aqueous pH. Hydrogel photolithography was also developing for 
integrating cells and sensing elements on culture surfaces (e.g. arrays of microwells for 
single cell capture and entrapment of enzymes inside hydrogel microstructures for local 
detection of cell metabolism). In both cases, PEG hydrogel lithography can be employed 
to control cell attachment, in the second approach hydrogel structures also carried 
enzymes and functioned as cell/sensors interfaces for diagnostics and tissue 
engineering.147 Some of these approaches showed promising results not only by 
biomimetic structures with micropattern nanostructures but also a suitable biochemical 
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environment. However they are in early stages, and more developments and 
understanding should be applied to create robust clinical applications. 
 
(4) Microfluidics technique deals with the handling of fluids in microenvironments, such 
as microchannels where the flow of fluids is laminar.143c Microfluidic patterning uses 
transient microchannels to flow coating agents over restricted areas of a surface.145 Once 
the coating is complete, the micro-channels are disassembled, and the patterned surface 
can be used. Microfluidics has shown advantages for the synthesis of polymer particles 
and been used to produce hydrogel particles with a well-defined size, shape and 
morphology.145, 148 Most importantly, during the encapsulation process, microfluidics can 
control the number of cells per particle and the overall encapsulation efficiency.148 Using 
this microfabrication technique, it can be found the use of alginate and gelatin as 
substrates,149 PEG 150 and typically made of PDMS.150b, 151 Important advances have 
occurred on microfluidic bioassays, which incorporate hydrogel scaffolds into surface-
accessible microchambers, driven by the strong demand for the application of 
spatiotemporally defined biochemical stimuli to construct in vivo-like conditions and 
perform real-time imaging of cell-matrix interactions.152 One emerging use of 
microfluidic systems is the generation of shape-controlled hydrogels (i.e., microfibers, 
microparticles, and hydrogel building blocks) for various biological applications.153 The 
diameters of the hollow and solid fibers can be manipulated by the flow rates.153b 
Furthermore, the microfluidic fabrication of cell-laden hydrogels is of great benefit for 
creating artificial scaffolds and should mimic the in vivo cellular environment.154 
Temperature-sensitive hydrogels obtained from natural materials (i.e., agarose, gelatin, 
collagen, and fibrin) have also been used to generate the microfluidic-based tissue 
architectures. 
 
5. Biomedical/Biotechnological applications 
 
5.1. Cell encapsulation 
TE construct comprises cells, GFs, and scaffolds. In a traditional TE strategy, cells are 
seeded on the surface of a porous 3D substrate with appropriate geometry and mechanical 
properties. In this scenario, cell-cell and cell-matrix interactions occur mainly in 2D. 
However, on in vivo conditions, these interactions happen in a 3D environment, with cells 
being embedded by the ECM. Bearing this in mind, researchers have been started to 
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encapsulate viable and functional cells into 3D environments that mimic the natural 
ECM.155 Several methods have been used to encapsulate cells in 3D structures, from 
simple gravitational dripping to more complex ones as microtechnologies 156 or additive 
manufacturing.157 This strategy has been shown interesting and promising results for 
different applications such as, (i) cell immunoisolation and drug delivery;158 (ii) storage 
and transport;159 and (iii) cell delivery.160 (Figure 8) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8: Schematic representation of the three applications of cell encapsulation 
technology: Cell delivery, Immunoprotection, and Storage&Transport. 
 
Understandably, it is necessary to choose wisely the biomaterial. It should be 
biocompatible and must be permeable to oxygen, nutrients and metabolites. Naturally-
derived hydrogels are attractive materials, as they have a similar structure to the ECM 
and can be processed under mild conditions, compatible with cells. Moreover, the low 
interfacial tension between the hydrogels and the environmental fluids results in low 
protein adsorption rate and cell adhesion, making them highly biocompatible. The soft 
and pliable nature of these gels reduce the mechanical irritation on the surrounding area, 
providing a high degree of permeability to nutrients and metabolites.161  
Besides biocompatibility and porosity, encapsulation strategies may require other 
properties that are constrained by the final application of the construct. If the system is 
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designed for cell delivery, then the matrix should be biodegradable. On the other hand, if 
the final aim is the release of a therapeutic molecule secreted by entrapped cells, the 
matrix must be robust and non-biodegradable. 
5.1.1. Immunoisolation and drug delivery 
Cell encapsulation has been widely studied as a way to avoid the host immune response 
elicited by transplanted cells. The strategy implies the encapsulation of cells within an 
artificial compartment, confined by a semipermeable membrane. This membrane must 
isolate cells from the immune system response – immunoisolation - while permitting the 
diffusion of small molecules like glucose, oxygen, therapeutic molecules and waste 
products.162 As a result, there is no need to use harmful immunosuppressant drugs after 
transplantation. Moreover, encapsulation technology also surpasses the shortage of 
donors as it allows not only allogenic but also xenogenic transplants to be performed.163 
When designing materials for this purpose one should bear in mind some properties that 
cannot be discarded. First, biomaterials should be selected to prevent cellular overgrowth 
on the encapsulated grafts while ensuring the free diffusion of nutrients, oxygen, and 
therapeutic molecules. Otherwise, the overgrowth of fibrous tissue would result in 
impaired diffusion profiles and subsequent cell death and graft failure. Secondly, they 
must be stable because the membrane cannot be disrupted after transplantation. 
Therefore, biodegradable materials with fast degradation kinetics should be avoided for 
the sake of capsule integrity and subsequent islet immunoprotection.164 Moreover, 
materials should have an adequate mechanical stiffness and toughness to handle the forces 
imposed at the implantation site without disruption.162 To improve those mechanical 
properties different geometries and chemical structures are being studied. These include 
the modification of the material with strengthening polymers, application of multiple 
layers,165 reinforcement with polyester meshes and decrease of the capsule size.164 Last, 
permeability is a central requirement in the design of cell encapsulation devices, which is 
tightly correlated with the performance of encapsulated. One important parameter to 
evaluate membrane permeability is the molecular weight cut-off (MWCO). It determines 
the minimum molecular weight measured in Daltons (Da), correspondingly minimum 
size, of a solute that is completely excluded by the semipermeable membrane. A MWCO 
of 50 to 150 kDa was reported as the most suitable for cell encapsulation purposes.162, 164 
Immunoisolation techniques have been studied as a treatment for different diseases, 
including heart infarction,166 kidney and liver failure,167 central nervous system 
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insufficiencies168 and widely for Diabetes Mellitus.165, 169 Inspired by the work of Lim 
and Sun (1980),170 islet immunoisolation studies started to consider hydrogels to produce 
spherical semipermeable membranes (capsules), that host only one to a few islets. Their 
small size, usually less than 1 mm, and spherical shape enhances the diffusion of oxygen 
and nutrients across the membrane, promoting cell viability and function.164 Other 
advantages of microcapsules include the mechanical stability in vivo, ease of 
manufacturing through different techniques and easy implantation by a simple 
injection.169a Among the various materials, alginate is the most studied for islet cell 
microencapsulation, although other materials as silk were also tested.171 Similarly to Lim 
and Sun, other authors reported the successful application of alginate - poly-L-lysine - 
alginate microcapsules, using different diabetic models like a rodent, pig, and canine.172 
Human clinical trials were also performed with promising results.169b, 172 though, 
researchers are still facing some complications, mostly regarding the lack of direct 
vasculature and the fibrotic overgrowth that occurs around the capsules. The lack of direct 
vasculature associated with encapsulated cells increases the probability of hypoxia, 
especially at the core of the device, then compromising the cell survival. Fibrotic 
overgrowth is normally a result of insufficient biocompatibility and has a negative impact 
on encapsulated islet function, which can lead to islet cell death.173 To tackle this issue, 
Vegas et al.174 used a modified alginate - triazole–thiomorpholine dioxide (TMTD) 
alginate – as a matrix to encapsulate human stem cell-derived β-cells (SC-β cells). While 
non-encapsulated SC-β cells were unable to restore a normoglycemic condition, TMTD 
alginate spheres have provided glycemic correction for over 70 days at all doses tested. 
Additionally, human C-peptide concentrations were higher when TMTD alginate was 
used. The immune response to these spheres was also quantified, and the results showed 
that TMTD alginate spheres had a lower number of cells related to an immune response 
to their surroundings as compared with other conditions, confirming a reduction in the 
fibrotic deposition. Further experiments as proteomics and histological processing have 
confirmed that the TMTD-based material was able to mitigate the fibrotic overgrowth 
while maintaining islets viable and functional. At last, long-term glycemic control was 
tested. For that, the created system was transplanted into mice and tracked for 174 days. 
The mice maintained the glycemic correction for the whole experimental period, with 
glucose levels similar to the wild-type, even when subjected to a glucose challenge. After 
six months, the capsules were retrieved, and no fibrotic overgrowth was noticed.  
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5.1.2 Storage and Transport 
Cell-based therapies have grown substantially in recent years as a treatment for numerous 
diseases including cardiovascular disease, neurodegenerative diseases, cancer, liver 
disease, diabetes, skeletal disorders and eye diseases.175 The pipeline from cell isolation 
to clinical practice implies a storage and transport step, meaning that cell preservation 
technology must evolve at the same pace to allow correct transport and storage.  
The entrapment of living cells within a 3D matrix has been reported as a way to improve 
cells viability after storage, both on cryo- and hypothermic preservation.159, 176 The 
presence of the biomaterial not only protects cells against the osmotic shock and 
mechanical stress, experienced during storage and recovery, but also provides cell 
membrane stabilization and supports the maintenance of cell-cell interactions.176-177 
Consequently, many researchers start to use and study encapsulation methods to store 
cells. For instance, alginate encapsulation has been investigated for its protective effect 
on the storage of rat hepatocytes,177 recombinant baby hamster kidney cells,178 hBMSCs, 
mouse embryonic stem cells (ESCs),179 corneal epithelial cells180 and adipose stem 
cells.159  
5.1.2. Cell delivery 
The encapsulation of cells inside 3D environments has also been shown promising results 
for tissue regeneration purposes, where the aim is to form tissue in vivo from a TE 
construct. Besides the aforementioned 3D structure, the encapsulation technique can 
simplify the handling process and allow a correct grafting of cells. Contrary to 
immunoisolation, in these cases the material should be biodegradable, allowing cell 
proliferation and ECM formation to restore the damaged organ. To be successful, the 
degradation rate should be adjusted to the tissue growth kinetics. Moreover, the 
degradation products must be cell-friendly to avoid adverse effects on encapsulated cells 
or in the host.181  
Researchers are using different materials and strategies to encapsulate and deliver cells. 
Fibrous protein-based hydrogels, like silk, keratin, elastin, and collagen have been shown 
very promising on this topic.182 Besides the structural, chemical and mechanical 
similarities with the ECM, they can be degraded by proteolytic enzymes once inside the 
human body.182 Carbohydrate-based materials, including mixtures183 or chemically 
modified184 materials, as well as hydrogel composites,123c are also very promising since 
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the modifications can improve and help on fine tune their degradation rate,183b, 185 
according to with the desired purpose. 
One interesting approach for cell delivery is the use of injectable cell-laden hydrogels.184, 
186 This strategy has called the attention of researchers mostly due to its non-invasive 
nature as well as the ease of handling and possibility to completely fill the defect. 
Recently, Liu et al..186a developed a thermosensitive carboxymethyl chitin hydrogel that 
sets at 37 ºC and it is degraded in the presence of lysozyme or hyaluronidase. These 
hydrogels were able to promote cell proliferation and survival in vitro and in vivo studies 
showed tissue compatibility and good in-situ gel formation.  
 
5.2. Application in Intervertebral Disc Regeneration 
Several polymers have been studied for intervertebral disc (IVD) regeneration, namely 
natural-origin polymers that can be used as hydrogel matrices or 3D porous scaffolds.187 
Despite the great advances using cell-free materials and growth factors, the use of 
acellular strategies combined with cells obtained from different sources is seen as the 
most promising research direction. Cell-based strategies directed to the regeneration of 
IVD focus mainly on the regeneration of the central nucleus (nucleus pulposus, NP), since 
it is in this tissue that disc degeneration initiates. The outer structure of the IVD, i.e. the 
annulus fibrosus (AF), suffers degeneration after the NP, mainly due to NP malfunction 
because of its loss of hydration and structure.188 So when choosing the right biomaterial 
to carry cells to the NP, several properties must be taken into account, namely (Table 2): 
 
Table 2. Biomaterial requirements as a cell carrier for IVD regeneration. 
 Problem Solution References 
1 
AF should be left intact as 
much as possible during 
surgical procedure 
Injectable material, so that only 
the area of the needle insertion in 
the AF is injured  
189 
2 
The material must be able to 
polymerise in situ only after 
injection * 
Polymerization can be achieved 
either by changes in pH, ion 
interaction, temperature or light 
exposure 
190,191 
3 
The cell-loaded material 
should improve NP 
properties, such as disc 
height and biomechanical 
The material’s mechanical 
properties should be as close as 
possible to the mechanical 
properties of the native NP tissue 
192 
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function, for the cells to 
remain viable 
4 
The biomaterial must 
provide an adequate 
environment for stimulation 
of NP cells phenotype 
The material must be able to 
absorb at least 80% of water, 
which is the amount of water in 
the NP  
193 
5 
The material should be 
biocompatible and 
biodegradable 
The degradability rate must have 
the same timing has the tissue’s 
rate of regeneration 
194 
*If the polymerised material can be injected or if the material does not polymerise in vivo it is very likely 
that the material will come right off through the needle hole, with cells included, on the first IVD loading. 
 
With all those requirements in mind, hydrogels stand out as the best type of material to 
be used for NP regeneration (Figure 9). Hydrogels can withstand complex loading and 
allow the complete filling of irregular defects.187 In the clinical setting, they possibly to 
be administered by using minimally invasive techniques, facilitating a good and faster 
surgical practice. Additionally, hydrogels present less risk of extrusion or migration, thus 
allowing to control the delivery of drugs or cells at the damaged site. Hydrogels for IVD 
repair may differ from physical crosslinking systems (e.g. ionic-crosslinked), which are 
obtained under mild conditions, to chemical crosslinking systems (e.g. photo- and 
enzyme-crosslinked) that present improved stability and mechanical properties. 
 
 
Figure 9: Ionically-crosslinked methacrylated GG (GG-MA) discs with a diameter of 7 
mm and a height of 4 mm.  
 
Several kinds of hydrogels have been studied for cartilage regeneration, as well as 
specifically designed for IVD TE strategies. There is a growing interest in natural-origin 
hydrogels, and besides their high biocompatibility, the economic aspect is another reason 
for it. The main reasons for why they are getting more attractive are their low toxicity and 
the wide range of possible TE strategies where they can be applied.195 Additionally, as 
most of the naturally occurring hydrogels are extracted and not synthesized, this greatly 
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reduces its manufacturing cost. However, they also require purification processing, which 
sometimes involves using severely toxic solvents and reagents. Even so, in general, they 
are less expensive to produce than synthetic hydrogels.  
Although natural-origin hydrogels offer a wide range of biological advantages, they lack 
the needed physical properties, such as solubility and adequate rate of degradation, which 
is too fast and does not allow the tissue to regenerate in such low time.196 Some examples 
of natural-origin hydrogels being investigated for IVD TE are alginate, 
carboxymethylcellulose, chitosan, collagen, gellan gum, hyaluronan and silk fibroin.48, 
130b, 192, 195a, 195c, 197 The advantages and disadvantages of using each one of these natural-
origin polymers in NP regeneration are indicated in Table 3.  
 
Table 3. Natural-origin hydrogels used in IVD TE strategies – advantages and 
disadvantages specific for NP regeneration. 
Natural Origin 
Hydrogels 
Advantages Disadvantages References 
Alginate 
- Polymerization 
under mild conditions 
- In situ injectability 
- closely mimics NP 
mechanical and cell-
adhesive properties 
- Limited control over 
mechanical properties, 
swelling ratio and 
degradation profile 
- High variability 
between batches due to 
impurities presence 
- Immunogenic 
- Difficult to sterilize 
and handle 
- Lack of informational 
structure 
for positive cell 
response 
197a,195c, 
197b,197c,197d  
 
Carboxymethyl
cellulose 
- Low-cost 
- FDA-approved 
- Commercially 
available in high-
purity forms  
- Lack of studies on 
IVD regeneration 
197e,197f  
 
Chitosan 
- Hydrophilic surface 
- Bioactive 
- Cell adherent 
- Antibacterial 
activity 
- Non immunogenic 
- Poor mechanical 
properties 
- Some level of toxicity 
(due to crosslinking 
agents) 
197a, 195c, 197g,192 
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- High variability 
between batches due to 
impurities presence 
Collagen 
- Non- immunogenic 
- Piezoelectric 
properties 
- Bioactive 
- Poor mechanical 
properties 
- High degradation rate 
- Some level of toxicity 
(due to crosslinking 
agents) 
197a,195c,197h 
Gellan Gum 
- Non- immunogenic 
- Very low 
manufacturing cost 
- Stable in long-term 
- Mechanical 
performance and 
rheological behavior 
similar to the native 
NP tissue 
- Non-angiogenic 
when methacrylated 
- Weak in physiological 
conditions in its native 
form due to the 
exchange of divalent 
cations by monovalent 
ones 
48, 197a, 197i,130b, 
197j 
 
Hyaluronan 
- Non-immunogenic 
- Easy control over 
polymer chain sizes 
- Bioactive 
- Osteogenic 
- Cytotoxic in high 
concentration 
- Batch-to-batch 
variations 
197a, 195c,197k, 197l 
Silk Fibroin 
- Good mechanical 
properties 
- Biocompatible 
- Controllable 
degradation rate 
- Can provide 
appropriate 
mechanical strength 
when combined with 
other polymers 
- Can only be used to 
create composite 
hydrogels due to 
inducible formation of 
crystalline b-sheet 
structure 
197m, 197n 
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6. Final remarks and future trends 
 
Natural-origin polymers derived from renewable resources, namely from algae, animal, 
plant, and microorganisms, are appealing for tissue engineering and regenerative 
medicine applications due to its similarities with the extracellular matrix, specific 
degradation rates, chemical versatility, and good biological performance without toxicity 
or immunological reactions. A variety of applications for these type of materials includes 
cell encapsulation and intervertebral disc (IVD) regeneration. Biomimetic strategies for 
tissue engineering and processing are focused on micro/nanoparticles, membranes, 
scaffolds, and hydrogels, alone or in combination. Hydrogels are of particular interest 
because of their high water content, biodegradability and compatibility, and mechanical 
properties which resemble those of nonosseous living tissues. Many efforts have been 
made to improve the hydrogels potential. Injectable hydrogels, including mixtures of 
organic-inorganic systems, will continue to be improved and applied in areas for tissue 
enhancement and regeneration. Moreover, specific microfabrication techniques will be 
improved to spatially pattern the environment at microscale. One disadvantage of 
processing hydrogels is difficult to shape them in predesigned geometries. A challenge 
for tissue engineering is producing 3D vascularized cellular constructs of clinically 
relevant size, shape and structural integrity. 
Conventional techniques used to fabricate structures include foam replica method, solvent 
casting and particulate-leaching, freeze drying, gas foaming, and phase separation. Rapid 
prototyping, supercritical fluid technology bioprinting, photolithography, microfluidics, 
and electrospinning, are more sophisticated techniques also used allowing the possibility 
of incorporating pharmaceutical agents and possibly cells.  
Additive manufacturing such as bioprinting and bioink presents a high potential in 
combination with the design and imaging techniques. This includes the evolution and 
understanding of microfluidic devices whose controlled environments provide the cell 
culture with more life-like conditions than traditional cell culture methods. The 
innovations of these systems at the micro and nanoscale will open a wide range of 
applications, from fundamental research up to regenerative medicine. 
The use of natural-derived polymers allows to better mimic the native ECM environment. 
Then, these molecules are very attractive for biomimetic strategies, including cell 
encapsulation. Nevertheless, their inherent properties are not enough to confer the perfect 
environment for cell growth and provide the proper mechanical properties. As a result, 
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they are commonly combined with other materials, both natural or synthetic, to obtain 
improved TE constructs. Thence, the development of new strategies or their translation 
to clinics are tightly dependent on the development and study of new biomaterials or 
combinations of well-established ones.  
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